The move by Eli Lilly came less than 24 hours after Johnson & Johnson paused further dosing in all of its COVID-19 vaccine candidate clinical trials while it investigated a volunteer's illness.
Copyright 2020 NPR
The move by Eli Lilly came less than 24 hours after Johnson & Johnson paused further dosing in all of its COVID-19 vaccine candidate clinical trials while it investigated a volunteer's illness.
Copyright 2020 NPR